Targeting the anti-angiogenic factors of preeclampsia: soluble endoglin and sFlt1 [ 2014 - 2018 ]

Also known as: Targeting the toxins of preeclampsia

Research Grant

[Cite as]

Researchers: Dr Tu'Uhevaha Kaitu'U-Lino (Principal investigator)

Brief description Preeclampsia is a severe disease of pregnancy - the placenta releases toxins in to mum's bloodstream that circulate her body and damage her organs. As there are no efficacious treatments, clinicians are forced to deliver babies irrespective of gestation. Although the two toxins of preeclampsia have been identified, little is known about their regulation. This project aims to elucidate the regulation of these toxins and design therapeutics that can prevent their release in the clinic.

Funding Amount $AUD 447,024.03

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]